A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer: HCRN GU14-182
MD Galsky, SK Pal, A Mortazavi, MI Milowsky, S George, S Gupta, MT Fleming, LH Dang, DM Geynisman, R Walling, RS Alter, EL Robin, J Wang, S Gupta, DD Chism, J Picus, G Philips, DI Quinn, NM Hahn, M Yu
MD Galsky, A Mortazavi, MI Milowsky, S George, S Gupta, MT Fleming, LH Dang, DM Geynisman, R Walling, RS Alter, M Kassar, J Wang, S Gupta, N Davis, J Picus, G Philips, DI Quinn, GK Haines III, NM Hahn, Q Zhao, M Yu, SK Pal
Trial Locations
All sites in which the trial HCRN-GU14-182 being conducted in.
